AXS-14 (esreboxetine) is Axsome’s novel, oral, investigational, highly selective and potent norepinephrine reuptake inhibitor ...

Canadian travellers impacted by escalating tensions in Mexico may be able to get a refund or modify their upcoming bookings as airlines offer more flexibility.

Fourth Quarter 2025 Revenues of $345.1 Million Reflect 21.9 Percent Growth and 20.0 Percent Organic Growth Over Fourth Quarter 2024 Revenues of ...

Many business owners build a gilded cage instead of a sellable asset because they cannot stop playing the hero.